Working… Menu

A Study of CBP-1018 in Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04928612
Recruitment Status : Not yet recruiting
First Posted : June 16, 2021
Last Update Posted : June 18, 2021
Information provided by (Responsible Party):
Coherent Biopharma (Suzhou) Co., Ltd.

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : October 2022
Estimated Study Completion Date : October 2023